RETINALGENIX DNA GPS

LIVE

Serial Number

98192292

Owner

Retinalgenix Technologies Inc.

Attorney

Megan E. Spitz

Filing Date

Sep 22, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

RETINALGENIX DNA GPS Trademark

Serial Number: 98192292

RETINALGENIX DNA GPS is a trademark filed by Retinalgenix Technologies Inc. on September 22, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Retinalgenix Technologies Inc. (4 trademarks)

1450 N. McDowell Blvd.
Petaluma, CA 94954

Entity Type: 03

Legal Representation

Attorney of Record

Megan E. Spitz

438 trademarks filed View all →

Correspondence Address

Megan E. Spitz BLANK ROME LLP

ONE LOGAN SQUARE, 8TH FLOOR

PHILADELPHIA, PA 19103

United States

Trademark Details

Filing Date

September 22, 2023

Registration Date

Not Registered

Published for Opposition

July 7, 2026

Goods & Services

Laboratory services for blood testing for medical analysis services for diagnostic and treatment purposes

Blood testing kits composed primarily of diagnostic test strips and reagents for blood analysis for medical purposes

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 7, 2026 NPUB

PUBLISHED FOR OPPOSITION

Jul 7, 2026 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jul 1, 2026 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jun 8, 2026 CNSA

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Jun 8, 2026 RCCK

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Dec 5, 2025 RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Jun 4, 2025 RCSC

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Dec 3, 2024 GNS3

LETTER OF SUSPENSION E-MAILED

Dec 3, 2024 GNSL

SUSPENSION LETTER WRITTEN

Dec 3, 2024 CNSL

TEAS/EMAIL CORRESPONDENCE ENTERED

Dec 2, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Dec 2, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 2, 2024 TROA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Sep 3, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Sep 3, 2024 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 31, 2024 GNRN

NON-FINAL ACTION E-MAILED

May 31, 2024 GNRT

NON-FINAL ACTION WRITTEN

May 31, 2024 CNRT

ASSIGNED TO EXAMINER

May 15, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 10, 2023 NWOS

NEW APPLICATION ENTERED

Sep 26, 2023 NWAP

Related Trademarks

More from this Owner

RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS

RETINALGENIX DNA/RNA GPS

RETINALGENIX RNA GPS

More in Same Class

CLEAN CARE SOLUTIONS

PET FOOD CULTURE

PLANT SCIENTIFIC

SINCE 1897

Serial #79388821

EXOCURA